Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Mephenesin chemical structure | |
| 3-(2-methylphenoxy)propane-1,2-diol IUPAC name | |
| CAS number 59-47-2 |
ATC code M03BX06 |
| PubChem 4059 |
DrugBank [1] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 182.216 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
- Main article: Muscle relaxing drugs
Mephenesin is a centrally acting muscle relaxant.
External links[]
- Bachmeyer C, Blum L, Fléchet M, Duriez P, Cabane J, Imbert J (1996). [Severe contact dermatitis caused by mephenesin]. Ann Dermatol Venereol 123 (3): 185–7.
- Ono H, Nakamura T, Ito H, Oka J, Fukuda H (1987). Rigidity in rats due to radio frequency decerebration and effects of chlorpromazine and mephenesin. Gen Pharmacol 18 (1): 57–9.
Skeletal muscle relaxants (M03) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peripherally acting (primarily antinicotinic, NMJ block) |
| ||||||||||||||||
| Centrally acting |
| ||||||||||||||||
| Directly acting | |||||||||||||||||
| {| class="navbox collapsible nowraplinks" style="margin:auto; " | |||||||||||||||||
| |||||||||||||||||
|}
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |